Chemotherapy and the Risk of Alzheimer's Disease in Colorectal Cancer Survivors: Evidence From the Medicare System

Time Trends in the Prevalence of Neurocognitive Disorders and Cognitive Impairment in the United States: The Effects of Disease Severity and Improved Ascertainment

(2018) Igor Akushevich et al.   JOURNAL OF ALZHEIMERS DISEASE

Propensity Score Methods for Bias Reduction in Observational Studies of Treatment Effect

(2018) Sindhu R. Johnson et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Pharmacological Modulation of GSAP Reduces Amyloid-β Levels and Tau Phosphorylation in a Mouse Model of Alzheimer's Disease with Plaques and Tangles

(2018) Jin Chu et al.   JOURNAL OF ALZHEIMERS DISEASE

Re-thinking Alzheimer's disease therapeutic targets using gene-based tests

(2018) Man Ki Kwok et al.   EBioMedicine

Risk of Alzheimer’s Disease Among Senior Medicare Beneficiaries Treated With Androgen Deprivation Therapy for Prostate Cancer

(2017) Seo Hyon Baik et al.   JOURNAL OF CLINICAL ONCOLOGY

Global patterns and trends in colorectal cancer incidence and mortality

(2016) Melina Arnold et al.   GUT

Do Cancer Drugs Counteract Neurodegeneration? Repurposing for Alzheimer’s Disease

(2016) Fiammetta Monacelli et al.   JOURNAL OF ALZHEIMERS DISEASE

Lack of support for bexarotene as a treatment for Alzheimer's disease

(2016) Eugene O'Hare et al.   NEUROPHARMACOLOGY

Cancer and Dementia

(2015) Mary Ganguli   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Chemobrain: A critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy

(2015) Xiao-Min Wang et al.   CYTOKINE

Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study

(2015) Lisa M. Hess et al.   GYNECOLOGIC ONCOLOGY

Bexarotene Blocks Calcium-Permeable Ion Channels Formed by Neurotoxic Alzheimer’s β-Amyloid Peptides

(2014) Jacques Fantini et al.   ACS Chemical Neuroscience

Fatal outcome of posterior “reversible” encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen

(2014) Natalija Dedić Plavetić et al.   World Journal of Surgical Oncology

Potential repurposing of oncology drugs for the treatment of Alzheimer's disease

(2013) Wataru Araki   BMC Medicine

Striking reduction of amyloid plaque burden in an Alzheimer's mouse model after chronic administration of carmustine

(2013) Crystal D Hayes et al.   BMC Medicine

Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907

(2013) Rachel A. Freedman et al.   BREAST CANCER RESEARCH AND TREATMENT

Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia

(2013) Vincent Koppelmans et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: A case report and literature review

(2012) Giuseppe FEMIA et al.   Asia-Pacific Journal of Clinical Oncology

Chemotherapy-Related Cognitive Dysfunction

(2012) Jeffrey S. Wefel et al.   Current Neurology and Neuroscience Reports

The Role of γ-Secretase Activating Protein (GSAP) and Imatinib in the Regulation of γ-Secretase Activity and Amyloid-β Generation

(2012) Ishrut Hussain et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Age Patterns of Incidence of Geriatric Disease in the U.S. Elderly Population: Medicare-Based Analysis

(2012) Igor Akushevich et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

ApoE-Directed Therapeutics Rapidly Clear  -Amyloid and Reverse Deficits in AD Mouse Models

(2012) P. E. Cramer et al.   SCIENCE

International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer

(2011) Jeffrey S Wefel et al.   LANCET ONCOLOGY

Relationship Between Chemotherapy Use and Cognitive Impairments in Older Women With Breast Cancer

(2010) Xianglin L. Du et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

(2010) Jeffrey S. Wefel et al.   CANCER

Tubulin-Independent Tau in Alzheimers Disease and Cancer: Implications for Disease Pathogenesis and Treatment

(2010) S. Souter et al.   Current Alzheimer Research

The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies

(2010) Kurt R. Brunden et al.   PHARMACOLOGICAL RESEARCH

Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy

(2010) Elina Zotova et al.   Alzheimers Research & Therapy

Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release

(2009) Riejanne Seigers et al.   BEHAVIOURAL BRAIN RESEARCH

Risk of Dementia in Older Breast Cancer Survivors: A Population-Based Cohort Study of the Association with Adjuvant Chemotherapy

(2009) Nancy N. Baxter et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Neurocognitive Changes in Cancer Survivors

(2008) Denise D. Correa et al.   CANCER JOURNAL

Patterns of Dementia Diagnosis in Surveillance, Epidemiology, and End Results Breast Cancer Survivors Who Use Chemotherapy

(2008) Julia E. Heck et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer

(2008) Mukaila A. Raji et al.   MEDICAL ONCOLOGY